Interleukin-10 and Gp130 cytokines in human multiple myeloma

Leukemia and Lymphoma

Volumn 34, Issue 1-2, 1999, Pages 63-70

  Klein, Bernard ^a   Lu, Zhao Yang ^b   Gu, Zong Jiang ^b   Costes, Valérie ^b   Jourdan, Michel ^b   Rossi, Jean François ^b  

^a INSERM   (France)

^b NONE

Author keywords

Cytokines; GP 130; Interleukin 10; Multiple myeloma

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 6; ONCOSTATIN M;

B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PLASMA CELL LEUKEMIA; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW;

EID: 0344731254     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909083381     Document Type: Review

References (66)

1. Moore, K. W., O'garra, A., de Waal Malefyt, R., Vieira, P. & Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol., 11, 165-190.
2. Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., Vries, J. E., Roncarolo, M. G., Mosmann, T. R. & Moore, K. W. (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology with Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA., 88, 1172-1176.
3. de Waal Malefyt, R., Abrams, J., Benett, B., Figdor, C. G. & de Vries, J. E. (1991) Interleukin-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174, 1209-1220.
4. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H. & de Vries, J. E. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp. Med., 174, 915-924.
5. Van Vlasselaer, P., Borremans, B., Van Den Heuvel, R., Van Gorp, U. & de Waal Malefyt, R. (1993) Interleukin-10 inhibits the osteogenic activity of mouse bone marrow. Blood., 82, 2361-2370.
6. Chen, W. F. & Zlotnik, A. (1991) IL-10: a novel cytotoxic T cell differentiation factor. J Immunol., 147, 528-534.
7. Bazan, J. F. (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U. S. A., 87, 6934-6938.
8. Ho, A. S. Y., Liu, Y., Khan, T. A., hsu, D. H., Bazan, J. F. & Moore, K. W. (1993) A Receptor for Interleukin-10 Is Related to Interferon Receptors. Proc. Natl. Acad. Sci. USA., 90, 11267-11271.
9. Gibbs, V. C. & Pennica, D. (1997) CRF2-4: isolation of cDNA clones encoding the human and mouse proteins. Gene, 186, 97-101.
10. Kotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W. & Pestka, S. (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J, 16, 5894-5903.
11. Spencer, S. D., Di Marco, F., Hooley, J., Pius-Meek, S., Bauer, M., Ryan, A. M., Sordat, B., Gibbs, V. C. & Aguet, M. (1998) The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp. Med., 187, 571-578.
12. Ho, A. S., Wei, S. H., Mui, A. L., Miyajima, A. & Moore, K. W. (1995) Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol. Cell Biol, 15, 5043-5053.
13. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N. & Pestka, S. (1996) Other kinases can substitute for Jak2 in signal transduction by interferon-gamma. J Biol Chem, 271, 17174-17182.
14. Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C., Yin, L., Pennica, D., Johnson, E. M.,Jr. & Schreiber, R. D. (1998) Disruption of the Jakl gene demonstrates obligatory and non-redundant roles of the Jaks in cytokine-induced biologic responses. Cell, 93, 373-383.
15. Wehinger, J., Gouilleux, F., Groner, B., Finke, J., Mertelsmann, R. & Weber-Nordt, R. M. (1996) IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett., 394, 365-370.
16. Finbloom, D. S. & Winestock, K. D. (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jakl and the differential assembly of STAT alpha and STAT3 complexes in human T cells and monocytes. J Immunol., 155, 1079-1090.
17. Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E. & Schreiber, R. D. (1996) Stat3 recruitment by two distinct ligand-induced, tyrosinephosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem, 271, 27954-27961.
18. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. (1993) Interleukin-10-deficient mice develop chronic entercolitis. Cell 75, 263-274.
19. MacMillan, R., Longmire, R. L., Yelenosky, R., Lang, J. E., Heath, V. & Craddock, C. G. (1972) Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. J. Immunol., 109, 1386.
20. Hibi, T. & Dosh, H. M. (1986) Limiting dilution analysis of the B cell compartment in human bone marrow. Eur. J. Immunol., 16, 139-145.
21. MacLennan, I. C. (1994) Germinal centers. Annu. Rev. Immunol., 12, 117-139.
22. Banchereau, J. & Rousset, F. (1991) Growth of human B lymphocytes in the CD40 system. Nature, 353, 678-681.
23. Choe, J., Kim, H. S., Armitage, R. J. & Choi, Y. S. (1997) The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. J. Immunol., 159, 3757-3766.
24. Dubois, B., Vanbervliet, B., Fayette, J., Massacrier, C., Van Kooten, C., Briere, F., Banchereau, J. & Caux, C. (1997) Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes [see comments]. J. Exp. Med., 185, 941-951.
25. Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J. & Liu, Y. J. (1995) Generation of memory B cells and plasma cells in vitro. Science, 268, 720-722.
26. Choe, J. & Choi, Y. S. (1998) IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol., 28, 508-515.
27. Slifka, M. K., Antia, R., Whitmire, J. K. & Ahmed, R. (1998) Humoral immunity due to long-lived plasma cells. Immunity., 8, 363-372.
28. Levy, Y. & Brouet, J. C. (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Invest., 93, 424-428.
29. Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., hsu, D. H., Kastelein, R., Moore, K. W. & Banchereau, J. (1992) Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA., 89, 1890-1893.
30. Burdin, N., Péronne, C., Banchereau, J. & Rousset, F. (1993) Epstein-Bar virus transformation induces B lymphocytes to produce human interleukin-10. J. Exp. Med., 177, 295-304.
31. Beatty, P. R., Krams, S. M. & Martinez, O. M. (1997) Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol., 158,4045-4051.
32. Tanner, J. E. & Tosato, G. (1992) Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6. Blood., 79, 452-459.
33. Masood, R., Zhang, Y., Bond, M. W., Scadden, D. T., Moudgil, T., Law, R. E., Kaplan, M. H., Jung, B., Espina, B. M. & Lunardi-Iskandar, Y. (1995) Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood, 85, 3423-3430.
34. Benjamin, D., Knobloch, T. J. & Dayton, M. A. (1992) Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood, 80, 1289-1298.
35. Blay, J. Y., Burdin, N., Rousset, F., Lenoir, G., Biron, P., Philip, T., Banchereau, J. & Favrot, M. (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood, 82, 2169-2174.
36. Voorzanger, N., Touitou, R., Garcia, E., Delecluse, H. J., Rousset, F., Joab, I., Favrot, M. C. & Blay, J. Y. (1996) Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res., 56, 5499-5505.
37. Kato, H., Kinoshita, T., Suzuki, S., Nagasaka, T., Hatano, S., Murate, T., Saito, H. & Hotta, T. (1998) Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma. Leuk. Lymphoma., 29, 71-79.
38. Bakkus, M., Heirman, C., Van Riet, I., Van Camp, B. & Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2336.
39. Klein, B., Zhang, X. G., Lu, Z. Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
40. Shimizu, S., Yoshioka, R., Hirose, Y., Susumu, S., Tachibana, J. & Konda, S. (1989) Establishment of two interleukin-6 (B cell stimulatory factor 2/interferon β2) dependent human bone marrow-derived myeloma cell lines. J. Exp. Med., 169, 339-344.
41. Zhang, X. G., Gaillard, J. P., Robillard, N., Lu, Z. Y., Gu, Z. J., Jourdan, M., Boiron, J. M., Bataille, R. & Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood., 83, 3654-3663.
42. Westendorf, J. J., Ahmann, G. J., Greipp, P. R., Witzig, T. E., Lust, J. A. & Jelinek, D. F. (1996) Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia, 10, 866-876.
43. Taga, T. & Kishimoto, T. (1997) Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol., 15, 797-819.
44. Klein, B. (1998) Update of gp130 cytokines in multiple myeloma. Curr. Opin. Hematol., 5, 186-191.
45. Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L. S. & Cosman, D. (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem., 271, 32635-32643.
46. Zhang, X. G., Gu, Z. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R. & Klein, B. (1994) Ciliary neurotropic factor, interleukin 11, leukemia inbitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med., 179, 1337-1342.
47. Nishimoto, N., Ogata, A., Shima, Y., Tani, Y., Ogawa, H., Nakagawa, M., Sugiyama, H., Yoshizaki, K. & Kishimoto, T. (1994) Oncostatin M, leukemia inhibitory factor, and interleukin-6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J. Exp. Med., 179, 1343-1347.
48. Westendorf, J. J. & Jelinek, D. F. (1996) Growth regulatory pathways in myeloma. Evidence of autocrine oncostatin M expression. J. Immunol., 157, 3081-3088.
49. Wijdenes, J., Heinrich, P. C., Muller Newen, G., Roche, C., Gu, Z. J., Clement, C. & Klein, B. (1995) Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur. J. Immunol., 25, 3474-3481.
50. Autissier, P., Liautard, J., Brochier, J. & Gaillard, J. P. (1997) Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule. Eur. J. Immunol., 27, 794-797.
51. Portier, M., Rajzbaum, G., Zhang, X. G., Attal, M., Rusalen, C., Wijdenes, J., Mannoni, P., Maraninchi, D., Piechaczyk, M., Bataille, R. & Klein, B. (1991) In vivo interleukin-6 gene expression in the tumoral environment in multiple myeloma. Eur. J. Immunol., 21, 1759-1762.
52. Uchiyama, H., Barut, B. A., Mohrbacher, A. F., Chauhan, D. & Anderson, K. C. (1993) Adhesion of Human Myeloma-Derived Cell Lines to Bone Marrow Stromal Cells Stimulates Interleukin-6 Secretion. Blood., 82, 3712-3720.
53. Lokhorst, H. M., Lamme, T., de Smet, M., Klein, S., de Weger, R. A., van Oers, R. & Bloem, A. C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood., 84, 2269-2277.
54. Bataille, R., Jourdan, M., Zhang, X. G. & Klein, B. (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Invest., 84, 2008-2011.
55. Ludwig, H., Nachbaur, D. M., Fritz, E., Krainer, M. & Huber, H. (1991) Interleukin-6 is a prognostic factor in multiple myeloma [letter]. Blood, 77, 2794-2795.
56. Klein, B., Wijdenes, J., Zhang, X. G., Jourdan, M., Boiron, J. M., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z. Y., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
57. Bataille, R., Barlogie, B., Lu, Z. Y., Rossi, J. F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. & Klein, B. (1995) Biologic effects of anti-interleukin-6 (IL-6) murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
58. Lu, Z. Y., Zhang, X. G., Wijdenes, J., Morel-Fournier, B., Harousseau, J. L., Bataille, R., Rossi, J. F. & Klein, B. (1995) Interleukin-10 is a growth factor for human myeloma cells. Blood, 85, 2521-2527.
59. Gu, Z. J., Costes, V., Lu, Z. Y., Zhang, X. G., Pitard, V., Moreau, J. F., Bataille, R., Wijdenes, J., Rossi, J. F. & Klein, B. (1996) Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood, 88, 3972-3986.
60. Merville, P., Rousset, F., Banchereau, J., Klein, B. & Betaille, R. (1992) Serum interleukin 10 in early stage multiple myeloma [letter]. Lancet, 340, 1544-1545.
61. Stasi, R., Brunetti, M., Bussa, S. & Pagano, A. (1997) Serum interleukin-10 in plasma-cell dyscrasias. Am. J. Hematol., 54, 335-337.
62. Lu, Z. Y., Gu, Z. J., Zhang, X. G., Wijdenes, J., Neddermann, P., Rossi, J. F. & Klein, B. (1995) Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines. FEBS Lett., 377, 515-518.
63. Bartl R. & Frisch B. (1998) Bone marrow biopsy and aspiration for diagnosis of multiple myeloma. In Myeloma, Biology and Management (Malpas J. S., Bergsagel D. E., Kyle R. A. & Anderson K. C., Eds), pp. 89-121. Oxford University Press, Oxford.
64. Manolagas, S. C. (1998) The role of IL-6 type cytokines and their receptors in bone. Ann. N. Y. Acad. Sci., 840, 194-204.
65. Lu, Z. Y., Brailly, H., Wijdenes, J., Bataille, R., Rossi, J. F. & Klein, B. (1995) Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. Blood., 86, 3123-3131.
66. Klein, B. & Brailly, H. (1995) Cytokine-binding proteins: stimulating antagonists. Immunol. Today, 16, 216-220.